Technology News and Research

RSS

Shrink Nanotechnologies files patent for CellAlign tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign, have been filed.

17 Sep 2010

Transcatheter Technologies implants transapical aortic valve in acute porcine model

Transcatheter Technologies GmbH (TT), an innovative medical device company that is developing a second-generation transcatheter aortic valve prosthesis, announced today that its proprietary transapical aortic valve has been successfully implanted in the acute porcine model.

17 Sep 2010

Researchers load biological molecules onto 'nanosprings'

Researchers at Oregon State University have reported the successful loading of biological molecules onto "nanosprings" - a type of nanostructure that has gained significant interest in recent years for its ability to maximize surface area in microreactors.

17 Sep 2010

Media reporting can reduce impact of infectious disease outbreaks

At the first sign of a disease pandemic, public health officials should begin strongly communicating about the extent of the outbreak and the steps that can be taken by the public to avoid infection. That's the recommendation of two mathematical biologists who have modified the most widely used infectious disease transmission model to account for the impact of news media coverage.

17 Sep 2010

Pharma Lynx licenses NewCardio's QTinno automated cardiac safety solution

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.

17 Sep 2010

AOptix, Aware to demonstrate combined biometrics system at Biometrics Consortium Conference

AOptix Technologies, Inc., a leading-edge developer of advanced iris biometrics products and long-distance wireless optical communications solutions, today announced that AOptix and Aware, Inc. will be demonstrating a prototype dual-factor iris and face biometrics system in the AOptix exhibition booth at the upcoming Biometrics Consortium Conference and Technology Expo. The event takes place in Tampa from September 21 to 23, 2010.

17 Sep 2010

Researchers decode key DNA in evolution of aging, development and fertility

UC Irvine researchers have deciphered how lowly fruit flies bred to rapidly develop and reproduce actually evolve over time. The findings, reported in the Sept. 15 online issue of Nature, contradict the long-held belief that sexual beings evolve the same way simpler organisms do and could fundamentally alter the direction of genetic research for new pharmaceuticals and other products.

17 Sep 2010

Aerocrine directs issue of new shares, convertible bonds to Novo A/S

Aerocrine AB today announces that on 15 September 2010 the Board, by virtue of authorization by the shareholders' meeting, decided to carry out a SEK 225 million directed issue of new shares and convertible bonds to Denmark-based Novo A/S, as well as a SEK 155.5 million new share issue with preferential rights to existing shareholders.

17 Sep 2010

Study suggests familial, contextual factors affect girls' pubertal timing

Girls in homes without a biological father are more likely to hit puberty at an earlier age, according to a new study led by researchers at the University of California, Berkeley's School of Public Health.

17 Sep 2010

Scripps Research Institute receives grant to develop DNA sequencing technology

Scripps Research Institute Professor Reza Ghadiri, Ph.D., has been awarded a four-year, $5.1 million grant as part of a National Institutes of Health (NIH) initiative to spur the development of the next generation of DNA sequencing technologies, which could enable biomedical researchers and health care workers to routinely sequence a person's DNA.

17 Sep 2010

Fred Hutchinson Cancer Center research team wins 2010 BioFlux Innovation Award

Fluxion Biosciences, Inc. announced today that a research team from Fred Hutchinson Cancer Center has won the 2010 BioFlux Innovation Award competition. Laura Sycuro, Ph.D., a post-doctoral research fellow in the lab of David Fredricks, M.D., authored the winning submission which focuses on screening and characterizing bacterial strains involved in biofilm-related infections known to affect women's reproductive health.

From Fluxion Biosciences 17 Sep 2010

Pall launches GeneDisc Rapid Microbiology System for advanced microbial quality monitoring

Pall Corporation, a global leader in filtration, separation and purification, today announced the introduction of the GeneDisc® Rapid Microbiology System for advanced microbial quality monitoring. This system represents Pall's latest quality assurance innovation for the pharmaceutical manufacturing industry.

From Pall Corporation 17 Sep 2010

Scientists discover simple molecular test to block GOAT enzyme

Scientists at The Scripps Research Institute have designed a new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the appetite and play a role in diabetes.

17 Sep 2010

Cytori Therapeutics extends distribution agreement with GE Healthcare

Cytori Therapeutics, Inc. has extended the term and modified the focus of its current distribution agreement with GE Healthcare. GE Healthcare's sales rights allow its sales force to sell Cytori technology in the research markets in select European markets and the US.

17 Sep 2010

FDA approves CRT-D device to treat heart failure patients

The U.S. Food and Drug Administration today approved a new indication for three cardiac resynchronization therapy defibrillators (CRT-D) used to treat certain heart failure patients.

17 Sep 2010

AdvaMed fights back against increased FDA scrutiny

A report issued Wednesday by the industry's main trade association Advanced Medical Technology Association (AdvaMed) "found that there were 101 of the most serious kinds of recalls of medical devices from Jan. 1, 2005 to May 1, 2010, a record that AdvaMed senior executive vice president David Nexon called 'remarkable' considering the number of devices on the market," CQ HealthBeat reports.

17 Sep 2010

China-Biotics files two new patent applications

China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced that it has submitted two new patent applications to the State Bureau of Intellect Property.

17 Sep 2010

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.

17 Sep 2010

BAC launches CaptureSelect technology for protein depletion from serum

BAC, the leading provider of antibody-based affinity purification technologies, announces the launch of CaptureSelect HumanPlasma14 for highly specific, reproducible depletion of the 14 most abundant proteins from human blood plasma or serum. HumanPlasma14 is designed for single-step, single-use depletion of more than 99% of the abundant proteins.

17 Sep 2010

Solta Medical's Fraxel re:store Dual system for actinic keratosis receives FDA 510(k) clearance

Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has received FDA 510(k) clearance of its Fraxel re:store®Dual for the treatment of actinic keratosis (AKs). The Fraxel re:store Dual system takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market.

17 Sep 2010